container

Court Overseeing Stryker Hip Lawsuits in New Jersey Establishes Dates for Bellwether Trials, Bernstein Liebhard LLP Reports

The Firm has filed numerous Stryker hip recall claims in this proceeding on behalf of individuals who were allegedly harmed by Stryker’s Rejuvenate and ABG II Modular-Neck Hip Stems.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Free Case Review
We look forward to the start of bellwether trials, as their outcomes could provide insight into how juries might rule in similar Stryker hip recall claims.

New York, New York (PRWEB) June 02, 2014

The judge overseeing hundreds of Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) in New Jersey’s Bergen County Superior Court has established dates for the proceeding’s bellwether trials. According to an Order issued on May 20, 2014 by Judge Brian R. Martinotti, the trials are scheduled to begin on June 15, 2015 and July 13, 2015. The Order also outlines the procedure for selecting specific Stryker hip recall claims for those trials. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

“Our Firm is representing a number of Stryker hip lawsuit clients whose cases are pending in this litigation. We look forward to the start of bellwether trials, as their outcomes could provide insight into how juries might rule in similar Stryker hip recall claims,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have allegedly been harmed by Rejuvenate and ABG II hip stems.

Stryker Hip Recall
Stryker Rejuvenate and ABG II hip stems were recalled in July 2012 because of their propensity to corrode and fret at the modular neck-junction, which can cause recipients to experience pain, swelling and adverse local tissue reactions. At the time the Stryker hip recall was announced, at least 20,000 Rejuvenate and ABG II hip stems had been sold worldwide, but it is not clear how many were actually implanted in patients. Stryker has advised all patients fitted with a recalled component to undergo medical screening to ensure it is working properly, even if they have not experienced any symptoms that would indicate otherwise.*

According to court documents, at least 1,220 Stryker hip lawsuits are now pending in Bergen County Superior Court. The Court has implemented an Early Mediation Program, and so far all 12 cases selected for Phase I of that program have been resolved. Additional Stryker hip lawsuits are slated to go through the mediation process over the next 30 days.

In addition to the Stryker hip recall claims that have been filed in New Jersey, court documents indicate that more than 800 additional lawsuits are pending in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

Individuals who have allegedly suffered debilitating injuries related to the Stryker hip recall for Rejuvenate and ABG II hip stems may be entitled to compensation. To find out more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*literature.ortho.stryker.com/files/REJUV_COM_23.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.strykerhiprecallclaims.com/
https://plus.google.com/115936073311125306742?rel=author